Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 14.30
-0.20 (-1.38%)
May 28, 2026, 4:14 PM GMT
4.00% (1Y)
| Market Cap | 63.68M +54.4% |
| Revenue (ttm) | 6.00M +50.0% |
| Net Income | 5.30M |
| EPS | 0.01 |
| Shares Out | 439.14M |
| PE Ratio | 12.01 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 698,744 |
| Open | 14.50 |
| Previous Close | 14.50 |
| Day's Range | 14.25 - 14.75 |
| 52-Week Range | 9.52 - 18.50 |
| Beta | 0.90 |
| Analysts | Strong Buy |
| Price Target | 50.00 (+249.65%) |
| Earnings Date | May 27, 2026 |
About Creo Medical Group
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needl... [Read more]
Industry Medical Devices
Sector Healthcare
Founded 2003
Employees 129
Stock Exchange London Stock Exchange AIM
Ticker Symbol CREO
Financial Performance
Financial StatementsNews
Creo Medical Group sees 50% surge in year-on-year revenues
Creo Medical Group reported revenues of £6mn for 2025, up 50% year-on-year, while second-half sales growth accelerated to 58%.
6 days ago - The Armchair Trader